• Equity PC Ratio   0.57
  • |
  • Index PC Ratio   1.14
  • |
  • Total PC Ratio   0.97
  • |
  • VIX PC Ratio   0.54
  • VIX 13.95
  • VXN 18.04
  • VXO -
  • ISEE 85.00

TruCharts Trading Strategies and Stock Buy/Sell Reports
(Show Details)


Chart Settings
No saved settings found!

Chart Type:
From: / / To: / /
Show detail in :
 Chart Skins:      
Price Overlays:





Indicator Windows:





Company Profile

Akorn, Inc. manufactures and markets diagnostic and therapeutic pharmaceuticals in the areas of ophthalmology, antidotes, anti-infectives, and controlled substances for pain management and anesthesia in the United States. The company?s Ophthalmic segment markets diagnostic products, including mydriatics and cycloplegics, anesthetics, topical stains, gonioscopic solutions, and angiography dyes, which are used in the office setting. It also sells therapeutic products, such as antibiotics, anti-infectives, steroids, steroid combinations, glaucoma medications, decongestants/antihistamines, and anti-edema medications to wholesalers, chain drug stores, and other national account customers. In addition, this segment offers non-pharmaceutical products, including various artificial tear solutions, preservative-free lubricating ointments, and eyelid cleansers. The company?s Hospital Drugs & Injectables segment markets hospital drug and injectable pharmaceutical products, including antidotes, anti-infectives, and controlled substances for pain management and anesthesia; and other pharmaceutical products. This segment markets products to hospitals through the wholesale distribution channel. Its Contract Services segment manufactures ophthalmic and injectable pharmaceutical products for third party pharmaceutical customers. The company?s customers include physicians, optometrists, hospitals, wholesalers, group purchasing organizations, and other pharmaceutical companies. It has strategic partnerships with Strides Arcolab Limited; Serum Institute of India, Ltd.; Hameln Pharmaceuticals; and Cipla, Ltd. The company was founded in 1971 and is headquartered in Lake Forest, Illinois.

YES
     
AKRX (Akorn Inc)
Last Trade 3.76 Date 9/19/2019
Change % 0.00 % Price Change 0.00
Open 3.76 52 Week High 13.7
High 3.76 52 Week Low 2.34
Low 3.76 Type stock
Volume 3291 Average Volume 1931593
Prev Close 3.76 Stock Exchange NASDAQ
Bid 3.71 Ask 3.77
Bid Size 60 Ask Size 6
1st Yr Estimated EPS Growth -1.1417 2nd Yr Estimated EPS Growth 0.5625
2 Years Forward Earning Yield 0.0997 2 Years Forward PE Ratio 10.0267
2 Years EV/Forward EBIT 2 Years EV/Forward EBITDA 10.6358
Book Value per Share 2.0703 Book Value Yield 0.5506
Buy Back Yield CAPE Ratio
Cash Return -0.102 Cash Flow per Share -0.5327
Cash Flow Yield -0.1417 Dividend Rate
Dividend Yield 5 Year Dividend Yield
Earning Yield -1.016 EV/EBIT
EV/EBITDA EV / Free Cash Flow
EV / Forward EBIT EV / Forward EBITDA 11.8419
EV / Forward Revenue 1.5866 EV / Pre Tax Income
EV / Revenue 1.7327 EV / Total Asset 0.8123
Expected Dividend Growth Rate Free Cash Flow per Share -0.9323
Free Caash Flow Ratio Free Cash Flow Yield -0.2479
Forward Calculation Style Forward Dividend Yield
Forward Earning Yield 0.0638 Forward PE Ratio 15.674
Forward Return on Asset 0.0214 Forward Return on Equity 0.1159
Normalized PE Ratio Payout Ratio 0.0
PB Ratio 1.816174 PB Ratio 10 Year Growth -0.03689
PB Ratio 3 Year Growth 2.926987 Cash Ratio 3 Year Average 893.1993
Price to Cash Flow Ratio PEG Payback
PEG Ratio PE Ratio
PE Ratio 10 Year Average PE Ratio 10 Year Growth
PE Ratio 10 Year High PE Ratio 10 Year Low
PE Ratio 1 Year Avg PE Ratio 1 Year High
PE Ratio 1 Year Low PE Ratio 3 Year Avg 28.960841
PE Ratio 5 Year Avg PE Ratio 5 Year High
PE Ratio 5 Year Low Free Cash Flow Ratio 10 Year Growth
Free Cash Flow Ratio 3 Year Avg 25.793642 Price Change 1 Month 1.301038
Price to Cash Ratio 2.660646 Price / EBITDA
Price to Sales Ratio 0.712611 Price to Sales Ratio 10 Year Growth -0.05316
Price to Sales Ratio 3 Year Avg 2.433722 Price to Sales Ratio 5 Year Avg
Sale per Share 5.2764 Sales Yield 1.4033
Sustainable Growth Rate -0.9745 Tangible Book Value per Share -2.0617
Tangible Book Value per Share 3 year Avg -1.1411 Tangible Book Value per Share 5 year Avg -3.7205
Total Asset per Share 11.2108 Total Yield
Working Capital per Share -3.9157 Working Capital per Share 3 Year Avg 4.1194
Working Capital per Share 5 Year Avg 3.7197 Beta 2.113329